Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Noseworthy

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Neuropharmacology|February 5, 2003
Treatment of multiple sclerosis and related disorders: what's new in the past 2 years?John H Noseworthy
Neurology|December 8, 2011
Three tough acts to followJohn H Noseworthy
Current Opinion in Neurology|July 15, 2003
Management of multiple sclerosis: current trials and future optionsJohn H Noseworthy
Mayo Clinic Proceedings|April 2, 2014
What is ahead for Mayo Clinic?John H Noseworthy
Neurology|September 27, 2006
How much can we learn from long-term extension trials in multiple sclerosis?John H Noseworthy
Neurology|July 1, 2009
Progress report and a farewellJohn H Noseworthy
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Neurology|April 24, 2002
Randomized controlled trials to assess therapies for multiple sclerosisDean M Wingerchuk, John H Noseworthy
Annual Review of Medicine|January 31, 2002
Multiple sclerosisB Mark Keegan, John H Noseworthy
Mayo Clinic Proceedings|November 23, 2016
Executive Leadership and Physician Well-being: Nine Organizational Strategies to Promote Engagement and Reduce BurnoutTait D Shanafelt, John H Noseworthy
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Neuropharmacology|February 5, 2003
Treatment of multiple sclerosis and related disorders: what's new in the past 2 years?John H Noseworthy
Neurology|December 8, 2011
Three tough acts to followJohn H Noseworthy
Current Opinion in Neurology|July 15, 2003
Management of multiple sclerosis: current trials and future optionsJohn H Noseworthy
Mayo Clinic Proceedings|April 2, 2014
What is ahead for Mayo Clinic?John H Noseworthy
Neurology|September 27, 2006
How much can we learn from long-term extension trials in multiple sclerosis?John H Noseworthy
Neurology|July 1, 2009
Progress report and a farewellJohn H Noseworthy
Nature Reviews. Drug Discovery|March 11, 2005
NatalizumabJohn H Noseworthy, Peter Kirkpatrick
Neurology|April 24, 2002
Randomized controlled trials to assess therapies for multiple sclerosisDean M Wingerchuk, John H Noseworthy
Annual Review of Medicine|January 31, 2002
Multiple sclerosisB Mark Keegan, John H Noseworthy
Mayo Clinic Proceedings|November 23, 2016
Executive Leadership and Physician Well-being: Nine Organizational Strategies to Promote Engagement and Reduce BurnoutTait D Shanafelt, John H Noseworthy
Pageof 3